Fresenius Medical Care AG (FMCQF) is the 86th largest of 300 Healthcare Services companies by market capitalisation, at 4.79 Bn, behind Erasca, Inc. at 4.89 Bn. It trades on a P/E of 4.57, 80% below the peer median of 22.87. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DVA | Davita Inc. | primary | H-14 | Healthcare Providers | HG-04 | 11.90 Bn | 10.22 | 0.85 | 11.21 Bn |
| 2 | RDNT | RadNet, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 5.52 Bn | 286.90 | 2.43 | 4.79 Bn |
| 3 | FMCQF | Fresenius Medical Care AG | primary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 4 | CON | Concentra Group Holdings Parent, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 4.28 Bn | 20.83 | 1.87 | 4.12 Bn |
| 5 | PRVA | Privia Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.57 Bn | 76.15 | 1.09 | 2.16 Bn |
| 6 | MD | Pediatrix Medical Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.15 Bn | 12.29 | 1.10 | 1.74 Bn |
| 7 | PGNY | Progyny, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.12 Bn | 27.02 | 1.62 | 1.89 Bn |
| 8 | SGRY | Surgery Partners, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 1.82 Bn | 22.26 | 0.54 | 1.61 Bn |
| 9 | USPH | U S Physical Therapy Inc /Nv | primary | H-14 | Healthcare Providers | HG-04 | 1.17 Bn | 23.44 | 1.44 | 1.14 Bn |
| 10 | EVH | Evolent Health, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.47 Bn | -0.92 | 0.22 | 0.33 Bn |
| 11 | SRTA | Strata Critical Medical, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.45 Bn | 11.19 | 1.76 | 0.43 Bn |
| 12 | SBC | SBC Medical Group Holdings Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.44 Bn | 11.72 | 2.53 | 0.26 Bn |
| 13 | INFU | InfuSystem Holdings, Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.60 | 1.70 | 0.24 Bn |
| 14 | AIRS | Airsculpt Technologies, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.19 Bn | -15.81 | 1.23 | 0.17 Bn |
| 15 | JYNT | JOINT Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.12 Bn | 30.75 | 1.97 | 0.09 Bn |
| 16 | RYOJ | rYojbaba Co., Ltd. | primary | H-14 | Healthcare Providers | HG-04 | 0.05 Bn | -47.64 | 6.80 | 0.05 Bn |
| 17 | BTMD | biote Corp. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.37 | 0.23 | 0.03 Bn |
| 18 | DCGO | DocGo Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.17 | 0.12 | 0.01 Bn |
| 19 | PIII | P3 Health Partners Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -0.11 | 0.02 | 0.01 Bn |
| 20 | EUDA | EUDA Health Holdings Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -9.10 | 3.74 | 0.02 Bn |
| 21 | SY | So-Young International Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -0.57 | 0.08 | -0.09 Bn |
| 22 | LDDD | Longduoduo Co Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 23 | AMS | American Shared Hospital Services | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -3.77 | 0.33 | 0.00 Bn |
| 24 | BMGL | Basel Medical Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | 10.57 | — | 0.01 Bn |
| 25 | LFST | LifeStance Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.09 | 0.00 | -0.22 Bn |
| 26 | STLNW | Starling Oncology, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.14 | 0.01 | -0.04 Bn |
| 27 | CDIX | Cardiff Lexington Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | — | — | 0.01 Bn |
| 28 | IVF | INVO Fertility, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.34 | 0.45 | 0.00 Bn |
| 29 | FCHS | First Choice Healthcare Solutions, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.05 | — | 0.00 Bn |
| 30 | NIVF | NewGenIvf Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.00 | 0.00 | 0.00 Bn |
| 31 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 32 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 443.31 Bn | 70.19 | 6.89 | 436.74 Bn |
| 33 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.74 Bn | 115.10 | 5.48 | 357.60 Bn |
| 34 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 354.24 Bn | 23.76 | 0.79 | 322.77 Bn |
| 35 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.46 Bn | 9.25 | 3.88 | 258.77 Bn |
| 36 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 183.04 Bn | 33.74 | 3.93 | 177.44 Bn |
| 37 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 38 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 39 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 40 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 125.02 Bn | 39.59 | 11.33 | 119.81 Bn |
| 41 | CVS | CVS HEALTH Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 122.38 Bn | 25.05 | 0.29 | 108.42 Bn |
| 42 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 117.84 Bn | 22.36 | 3.14 | 109.02 Bn |
| 43 | HCA | HCA Healthcare, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 93.33 Bn | 11.91 | 1.20 | 92.32 Bn |
| 44 | ELV | Elevance Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 86.47 Bn | 17.48 | 0.43 | 50.52 Bn |
| 45 | CI | Cigna Group | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 73.02 Bn | 10.62 | 0.26 | 65.76 Bn |
| 46 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 66.27 Bn | 18.03 | 3.16 | 65.73 Bn |
| 47 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 59.59 Bn | 19.30 | 3.08 | 58.35 Bn |
| 48 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 54.19 Bn | 34.38 | 6.89 | 53.69 Bn |
| 49 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.33 Bn | 11.23 | 0.98 | 44.95 Bn |
| 50 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 49.60 Bn | 49.42 | 7.62 | 45.35 Bn |
| 51 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.48 Bn | 52.52 | 2.13 | 48.62 Bn |
| 52 | HUM | Humana Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 48.22 Bn | 35.15 | 0.33 | 24.35 Bn |
| 53 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.79 Bn | -24.76 | — | 43.79 Bn |
| 54 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 55 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.70 Bn | 52.41 | 3.13 | 32.24 Bn |
| 56 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.06 Bn | 32.07 | 6.45 | 30.11 Bn |
| 57 | CNC | Centene Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 31.79 Bn | -6.23 | 0.16 | 4.73 Bn |
| 58 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 59 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.54 Bn | 14.41 | 1.39 | 27.44 Bn |
| 60 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 61 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.23 Bn | 15.65 | 4.34 | 20.69 Bn |
| 62 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.94 Bn | 43.58 | 7.20 | 23.51 Bn |
| 63 | THC | Tenet Healthcare Corp | secondary | H-13 | Healthcare Providers | HG-04 | 22.50 Bn | 10.04 | 1.03 | 20.33 Bn |
| 64 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 65 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.02 Bn | 26.01 | 3.48 | 20.54 Bn |
| 66 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 67 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.20 Bn | 21.48 | 2.14 | 17.79 Bn |
| 68 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.47 Bn | 31.47 | 5.86 | 17.36 Bn |
| 69 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.01 Bn | 31.84 | 3.94 | 16.64 Bn |
| 70 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.65 Bn | 32.07 | 4.65 | 16.03 Bn |
| 71 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.21 Bn | 11.62 | 0.92 | 15.46 Bn |
| 72 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 73 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.55 Bn | 10.84 | 1.87 | 15.15 Bn |
| 74 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.22 Bn | 16.17 | 3.31 | 13.60 Bn |
| 75 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | 16.98 | 6.00 | 13.78 Bn |
| 76 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.38 Bn | 40.38 | 4.09 | 13.77 Bn |
| 77 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.66 Bn | 550.61 | 1.14 | 10.51 Bn |
| 78 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.58 Bn | 30.43 | 7.56 | 12.35 Bn |
| 79 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.58 Bn | 78.36 | 8.36 | 11.92 Bn |
| 80 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.34 Bn | 52.34 | 2.92 | 12.20 Bn |
| 81 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 82 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 11.66 Bn | 30.93 | 2.70 | 11.60 Bn |
| 83 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.32 Bn | -37.78 | 107.81 | 10.63 Bn |
| 84 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.89 Bn | -70.84 | 14.02 | 10.57 Bn |
| 85 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.15 | 17.26 | 10.46 Bn |
| 86 | UHS | Universal Health Services Inc | secondary | H-13 | Healthcare Providers | HG-04 | 10.51 Bn | 6.89 | 0.58 | 10.37 Bn |
| 87 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.11 Bn | 18.88 | 3.21 | 9.51 Bn |
| 88 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.05 Bn | -26.35 | — | 9.29 Bn |
| 89 | MOH | Molina Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 9.95 Bn | -1,421.05 | 0.22 | 1.03 Bn |
| 90 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.79 Bn | -13.35 | 144.68 | 8.62 Bn |
| 91 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 92 | OSCR | Oscar Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 9.53 Bn | 17.30 | 0.62 | 0.98 Bn |
| 93 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.53 Bn | 25.39 | 3.12 | 9.00 Bn |
| 94 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 95 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.96 Bn | -47.63 | — | 8.96 Bn |
| 96 | SLFIF | Sun Life Financial Inc | secondary | F-12 | Insurance | FG-04 | 8.56 Bn | 3.55 | — | 3.96 Bn |
| 97 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 7.76 Bn | 21.38 | 1.97 | 7.56 Bn |
| 98 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.56 | 4.54 | 6.92 Bn |
| 99 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.23 Bn | 67.32 | 10.04 | 6.84 Bn |
| 100 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.37 Bn | -20.43 | 2.00 | 6.17 Bn |
| 101 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 102 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 103 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.87 | 10.50 | 6.09 Bn |
| 104 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.15 Bn | 0.08 | — | 6.15 Bn |
| 105 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 106 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 5.98 Bn | 113.00 | 5.81 | 5.26 Bn |
| 107 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.71 | 32.00 | 5.64 Bn |
| 108 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.93 Bn | -5.27 | 2.63 | 5.63 Bn |
| 109 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.83 Bn | -33.11 | 1,160.93 | 5.65 Bn |
| 110 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.51 Bn | 35.10 | 3.86 | 5.40 Bn |
| 111 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 112 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.19 Bn | 35.68 | 3.29 | 4.74 Bn |
| 113 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.89 Bn | -17.03 | — | 4.89 Bn |
| 114 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.76 Bn | 12.50 | 4.18 | 3.80 Bn |
| 115 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.68 Bn | 48.56 | 3.46 | 4.45 Bn |
| 116 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.69 | — | 4.67 Bn |
| 117 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.34 Bn | 22.87 | 2.95 | 3.82 Bn |
| 118 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.29 Bn | 33.39 | 2.33 | 4.27 Bn |
| 119 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -11.83 | — | 4.18 Bn |
| 120 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.13 Bn | 11.63 | 3.10 | 3.91 Bn |
| 121 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | -7.94 | 1,126.80 | 4.06 Bn |
| 122 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.03 Bn | 120.71 | 1.87 | 3.73 Bn |
| 123 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.48 | — | 4.00 Bn |
| 124 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 4.00 Bn | -286.64 | 4.84 | 3.41 Bn |
| 125 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 126 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 127 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -45.13 | — | 3.80 Bn |
| 128 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.67 Bn | -45.48 | 4,678.06 | 3.67 Bn |
| 129 | OPCH | Option Care Health, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 3.62 Bn | 17.26 | 0.64 | 3.42 Bn |
| 130 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -76.58 | 5.93 | 3.14 Bn |
| 131 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 132 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.79 | 30.64 | 2.88 Bn |
| 133 | RSMDF | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.54 Bn | 2.34 | 0.63 | 2.07 Bn |
| 134 | CRVL | Corvel Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 3.41 Bn | — | — | 3.06 Bn |
| 135 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.40 Bn | 123.33 | 3.18 | 2.53 Bn |
| 136 | WRBY | Warby Parker Inc. | secondary | D-10 | Apparel and Luxury | DG-04 | 3.03 Bn | 390.92 | 3.32 | 2.73 Bn |
| 137 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.98 Bn | 17.41 | 4.46 | 2.51 Bn |
| 138 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -10.96 | 593.06 | 2.44 Bn |
| 139 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.57 | 79.61 | 2.48 Bn |
| 140 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -10.83 | 394.49 | 2.81 Bn |
| 141 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -14.90 | 6.24 | 2.10 Bn |
| 142 | ALHC | Alignment Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.70 Bn | 66.36 | 0.59 | 2.00 Bn |
| 143 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.66 Bn | -22.42 | 2.03 | 2.56 Bn |
| 144 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.36 | — | 2.64 Bn |
| 145 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.54 | 0.06 | -3.19 Bn |
| 146 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -61.67 | — | 2.60 Bn |
| 147 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | -7.41 | — | 2.59 Bn |
| 148 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.58 Bn | 244.35 | 4.53 | 2.41 Bn |
| 149 | ACHC | Acadia Healthcare Company, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 2.57 Bn | -2.95 | 0.76 | 2.40 Bn |
| 150 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.52 Bn | -55.84 | 41.09 | 2.51 Bn |
| 151 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.51 Bn | -169.96 | 10.01 | 2.40 Bn |
| 152 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 153 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.71 | 3.10 | 2.07 Bn |
| 154 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.50 | 2.51 | 1.60 Bn |
| 155 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 156 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -5.95 | 4.28 | 1.94 Bn |
| 157 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.11 | 13.44 | 2.28 Bn |
| 158 | CLOV | Clover Health Investments, Corp. /De | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.28 Bn | -124.19 | 0.92 | 2.04 Bn |
| 159 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -3.87 | — | 2.00 Bn |
| 160 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.25 Bn | -57.87 | 9.16 | 2.18 Bn |
| 161 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.18 Bn | -41.21 | — | 1.87 Bn |
| 162 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.16 Bn | 29.86 | 3.42 | 2.15 Bn |
| 163 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.70 | 6.76 | 1.66 Bn |
| 164 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 2,033.16 | 2.03 Bn |
| 165 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.99 Bn | 79.32 | 6.50 | 1.83 Bn |
| 166 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.91 Bn | 14.12 | 2.12 | 1.59 Bn |
| 167 | ASTH | Astrana Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.87 Bn | 53.42 | 0.49 | 1.47 Bn |
| 168 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.83 Bn | -12.32 | 2.62 | 1.39 Bn |
| 169 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.81 Bn | 27.63 | 6.91 | 1.44 Bn |
| 170 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.71 Bn | 29.50 | 16.63 | 1.63 Bn |
| 171 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | 170.39 | 16.23 | 1.60 Bn |
| 172 | ARDT | Ardent Health, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.58 Bn | 9.35 | 0.25 | 0.85 Bn |
| 173 | AGL | agilon health, inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.55 Bn | -6.70 | 0.26 | 1.37 Bn |
| 174 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.91 | 3.01 | 0.97 Bn |
| 175 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 176 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.53 Bn | 39.21 | 1.23 | 1.24 Bn |
| 177 | HCSG | Healthcare Services Group Inc | secondary | I-27 | Business Services | IG-06 | 1.51 Bn | 12.26 | 0.81 | 1.34 Bn |
| 178 | INNV | InnovAge Holding Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 1.50 Bn | -96.74 | 1.59 | 1.37 Bn |
| 179 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 180 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 181 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.70 | — | 1.43 Bn |
| 182 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.67 | — | 1.42 Bn |
| 183 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.42 Bn | 25.07 | 1.03 | 1.38 Bn |
| 184 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 185 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | 82.16 | 36.50 | 1.40 Bn |
| 186 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.40 Bn | -12.73 | 1.72 | 1.28 Bn |
| 187 | EYE | National Vision Holdings, Inc. | secondary | D-36 | Retail | DG-10 | 1.36 Bn | 48.83 | 0.69 | 1.32 Bn |
| 188 | NUTX | Nutex Health Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.36 Bn | 4.98 | 1.60 | 1.15 Bn |
| 189 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.52 | 3.97 | 1.21 Bn |
| 190 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.32 Bn | -20.85 | 1.27 | 0.86 Bn |
| 191 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.31 Bn | -9.95 | 13.76 | 0.95 Bn |
| 192 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.77 | 0.76 | 0.98 Bn |
| 193 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.77 | — | 1.02 Bn |
| 194 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.22 Bn | -386.79 | 2.60 | 1.15 Bn |
| 195 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -28.00 | 3.10 | 1.11 Bn |
| 196 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | 61.54 | 3.50 | 1.01 Bn |
| 197 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | -10.30 | 3.50 | 0.90 Bn |
| 198 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.18 Bn | 10.88 | 0.75 | 0.96 Bn |
| 199 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 200 | UTI | Universal Technical Institute Inc | secondary | D-28 | Consumer Services | DG-09 | 1.16 Bn | 33.93 | 1.32 | 0.99 Bn |
| 201 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -30.70 | 1.98 | 0.86 Bn |
| 202 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.16 Bn | 12.53 | — | 1.05 Bn |
| 203 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -5.32 | — | 1.09 Bn |
| 204 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.95 | 1.08 Bn |
| 205 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.40 | 12.35 | 1.01 Bn |
| 206 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 207 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.03 | — | 0.92 Bn |
| 208 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.11 | 2.55 | 0.47 Bn |
| 209 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 210 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -11.54 | — | 0.73 Bn |
| 211 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.92 Bn | 15.03 | 1.59 | 0.89 Bn |
| 212 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -48.72 | — | 0.91 Bn |
| 213 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -9.97 | 369.48 | 0.83 Bn |
| 214 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.82 Bn | -56.12 | 3.83 | 0.67 Bn |
| 215 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.91 | 9.10 | 0.66 Bn |
| 216 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.89 | 95.78 | 0.79 Bn |
| 217 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.79 Bn | -10.78 | 6.61 | 0.61 Bn |
| 218 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 15.72 | 0.93 | 0.60 Bn |
| 219 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.42 | 3.04 | 0.54 Bn |
| 220 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.24 | 5.24 | 0.49 Bn |
| 221 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -38.15 | 5.90 | 0.65 Bn |
| 222 | WOOF | Petco Health & Wellness Company, Inc. | secondary | S-13 | Staples Retail | SG-06 | 0.70 Bn | 28.24 | 0.12 | 0.41 Bn |
| 223 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 224 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.65 Bn | -42.42 | 12.41 | 0.63 Bn |
| 225 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.19 | 11.84 | 0.54 Bn |
| 226 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.07 | 1.70 | 0.38 Bn |
| 227 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.64 Bn | -17.31 | 1.99 | 0.58 Bn |
| 228 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 229 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -340,055.90 | — | 0.60 Bn |
| 230 | BRSYF | Brainsway Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 60.53 | 9.76 | 0.53 Bn |
| 231 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,165.03 | 6.03 | 0.48 Bn |
| 232 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -16.41 | 1.78 | 0.52 Bn |
| 233 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 234 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -17.80 | — | 0.54 Bn |
| 235 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.37 | 334.91 | 0.41 Bn |
| 236 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.52 Bn | -13.14 | 2.07 | 0.48 Bn |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.36 | 4.46 | 0.38 Bn |
| 238 | SENS | Senseonics Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.51 Bn | -4.64 | 10.46 | 0.27 Bn |
| 239 | CERS | Cerus Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | -27.93 | 2.02 | 0.45 Bn |
| 240 | DDD | 3D Systems Corp | secondary | I-12 | Machinery | IG-02 | 0.50 Bn | -10.00 | 1.30 | 0.38 Bn |
| 241 | TCMD | Tactile Systems Technology Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.50 Bn | 20.17 | 1.43 | 0.42 Bn |
| 242 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.41 | 22.27 | 0.22 Bn |
| 243 | NPCE | NeuroPace Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.49 Bn | -25.97 | 4.99 | 0.44 Bn |
| 244 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 78.36 | 0.23 Bn |
| 245 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.99 | 28.37 | 0.25 Bn |
| 246 | MCTA | Charming Medical Ltd | secondary | D-29 | Consumer Services | DG-09 | 0.45 Bn | -42,242.59 | 92.66 | 0.44 Bn |
| 247 | MTLS | Materialise Nv | secondary | T-20 | Business Applications | TG-03 | 0.44 Bn | 28.60 | 1.38 | 0.44 Bn |
| 248 | SGHT | Sight Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.44 Bn | -20.26 | 5.27 | 0.36 Bn |
| 249 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 250 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.43 | — | 0.26 Bn |
| 251 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.40 | 9.92 | 0.39 Bn |
| 252 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.86 | 11.34 | 0.42 Bn |
| 253 | CARL | Carlsmed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.41 Bn | -11.27 | 6.47 | 0.30 Bn |
| 254 | SI | Shoulder Innovations, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.41 Bn | -11.66 | 6.80 | 0.31 Bn |
| 255 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -52.78 | — | 0.41 Bn |
| 256 | CYH | Community Health Systems Inc | secondary | H-13 | Healthcare Providers | HG-04 | 0.40 Bn | 2.40 | 0.03 | 0.25 Bn |
| 257 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.14 | 39.23 | 0.19 Bn |
| 258 | AUNA | Auna S.A. | secondary | H-13 | Healthcare Providers | HG-04 | 0.38 Bn | 3.80 | 0.08 | 0.23 Bn |
| 259 | OFIX | Orthofix Medical Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.36 Bn | -8.34 | 0.44 | 0.26 Bn |
| 260 | OBIO | Orchestra BioMed Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.35 Bn | -5.83 | 10.86 | 0.15 Bn |
| 261 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 262 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 263 | CV | CapsoVision, Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.32 Bn | -11.62 | 22.10 | 0.31 Bn |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.47 | 0.15 Bn |
| 265 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.28 | 7.49 | 0.27 Bn |
| 266 | SMTI | Sanara MedTech Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | -9.84 | 2.10 | 0.30 Bn |
| 267 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | 3.45 | 0.30 | 0.08 Bn |
| 268 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.02 | — | 0.30 Bn |
| 269 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.67 | 0.38 | 0.15 Bn |
| 270 | TMCI | Treace Medical Concepts, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.29 Bn | -5.13 | 1.44 | 0.25 Bn |
| 271 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 272 | TLSI | TriSalus Life Sciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -4.74 | 6.17 | 0.23 Bn |
| 273 | ANIK | Anika Therapeutics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -130.67 | 2.30 | 0.24 Bn |
| 274 | TBI | TrueBlue, Inc. | secondary | I-25 | Business Services | IG-06 | 0.28 Bn | -4.86 | 0.16 | 0.25 Bn |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -1.94 | — | 0.27 Bn |
| 276 | RXST | RxSight, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.27 Bn | -6.85 | 2.08 | -0.14 Bn |
| 277 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.70 | 1.18 | 0.10 Bn |
| 278 | PROF | Profound Medical Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | 3.71 | 12.93 | 0.21 Bn |
| 279 | AHG | Akso Health Group | secondary | H-16 | Healthcare Providers | HG-04 | 0.24 Bn | — | 18.75 | 0.24 Bn |
| 280 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 281 | ELMD | Electromed, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 19.73 | 3.02 | 0.20 Bn |
| 282 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.43 | 6.13 | 0.13 Bn |
| 283 | STIM | Neuronetics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | -6.96 | 1.43 | 0.20 Bn |
| 284 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 285 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.33 | 7.32 | 0.21 Bn |
| 286 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.05 | — | 0.21 Bn |
| 287 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -55.91 | 3.00 | 0.18 Bn |
| 288 | ORGO | Organogenesis Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.20 Bn | -2.00 | 0.44 | 0.15 Bn |
| 289 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.59 | — | 0.20 Bn |
| 290 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -38.89 | 8.50 | 0.20 Bn |
| 291 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.17 | 14.71 | 0.16 Bn |
| 292 | PDEX | Pro Dex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.20 Bn | 14.39 | 2.54 | 0.19 Bn |
| 293 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.55 | 108.38 | 0.15 Bn |
| 294 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -29.09 | — | 0.19 Bn |
| 295 | NNBR | Nn Inc | secondary | I-09 | Machinery | IG-02 | 0.18 Bn | -4.96 | 0.40 | 0.17 Bn |
| 296 | HSDT | Solana Co | secondary | F-22 | Capital Markets | FG-05 | 0.18 Bn | -1.12 | 14.60 | 0.17 Bn |
| 297 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -1.42 | — | 0.12 Bn |
| 298 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 299 | NAKA | Nakamoto Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 0.16 Bn | -0.38 | 4.03 | 0.14 Bn |
| 300 | RANI | Rani Therapeutics Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -4.82 | 32.48 | 0.16 Bn |